SCHEMBL8262189

SCHEMBL8262189

NCC(O)C1(c2ccc(Cl)cc2)CCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 14/20 0.53
SLC6A3 Q01959 14/20 0.53
CYP3A4 P08684 2/20 0.53
ALOX15 P16050 2/20 0.53
TSHR P16473 2/20 0.53
TP53 P04637 1/20 0.53
SLC6A2 P23975 6/20 0.48
CHRM2 P08172 1/20 0.48
ADRA2A P08913 1/20 0.48
ADRA2B P18089 1/20 0.48
ADRA2C P18825 1/20 0.48
HTR2A P28223 1/20 0.48
OPRK1 P41145 1/20 0.48
HTR2B P41595 1/20 0.48
KCNH2 Q12809 1/20 0.48
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
MAPK1 P28482 1/20 0.47
HDAC4 P56524 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3444149 0.83 CYP3A4 (0.49) SLC6A4SLC6A3CYP3A4ALOX15TSHR
SCHEMBL13107057 0.83 CYP3A4 (0.49) SLC6A4SLC6A3CYP3A4ALOX15TSHR
SCHEMBL3444017 0.83 CYP3A4 (0.49) SLC6A4SLC6A3CYP3A4ALOX15TSHR
SCHEMBL16507234 0.82 SLC6A4 (0.55) SLC6A4SLC6A3SLC6A2KCNH2CYP2D6
SCHEMBL25314436 0.81 SLC6A4 (0.68) SLC6A4SLC6A3CYP3A4ALOX15TSHR
Hydrochloric Acid SCHEMBL11111073 0.78 CYP3A4 (0.63) SLC6A4SLC6A3CYP3A4ALOX15TSHR
Hydrochloric Acid SCHEMBL5313752 0.78 CYP3A4 (0.51) SLC6A4SLC6A3CYP3A4ALOX15TSHR
SCHEMBL16521004 0.78 SLC6A3 (0.48) SLC6A4SLC6A3CYP3A4ALOX15TSHR
SCHEMBL16521006 0.76 SLC6A4 (0.47) SLC6A4SLC6A3CYP3A4ALOX15TSHR
SCHEMBL622964 0.76 CYP3A4 (0.43) SLC6A4SLC6A3CYP3A4ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006091697-A1 DOPAMINE TRANSPORTER INHIBITORS FOR USE IN TREATMENT OF MOVEMENT DISORDERS AND OTHER CNS INDICATIONS PSYCHENOMICS, INC. (US) 2006-08-31 WO disclosed